Familial isolated congenital asplenia

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:101351OMIM:271400Q89.0
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Familial isolated congenital asplenia (FICA), also known as isolated congenital asplenia or hereditary splenic agenesis, is an extremely rare condition characterized by the complete absence of the spleen from birth without any other associated developmental abnormalities. Unlike asplenia that occurs as part of heterotaxy syndromes (where the arrangement of internal organs is disrupted), familial isolated congenital asplenia occurs as an isolated finding, meaning the heart and other organs develop normally. The condition primarily affects the immune system, as the spleen plays a critical role in filtering blood and mounting immune responses against encapsulated bacteria. Patients with FICA are at severely increased risk of life-threatening, overwhelming bacterial infections (known as overwhelming post-splenectomy infection or OPSI-like sepsis), particularly from encapsulated organisms such as Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis. These fulminant infections can occur at any age but are especially dangerous in infancy and early childhood, and they carry a high mortality rate if not promptly recognized and treated. The condition may go undiagnosed until a severe septic episode occurs, as the absence of the spleen may not cause obvious symptoms otherwise. Characteristic blood smear findings include Howell-Jolly bodies (nuclear remnants in red blood cells that are normally removed by the spleen). Management of familial isolated congenital asplenia focuses on infection prevention and includes lifelong prophylactic antibiotics (typically penicillin, especially in childhood), comprehensive vaccination against encapsulated bacteria (pneumococcal, meningococcal, and Haemophilus influenzae type b vaccines), and prompt empiric antibiotic treatment for any febrile illness. Patient and family education about the risks of infection is essential. Mutations in the RPSA gene (encoding ribosomal protein SA) have been identified as a cause of this condition in multiple families. Genetic counseling is recommended for affected families.

Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Familial isolated congenital asplenia.

View clinical trials →

No actively recruiting trials found for Familial isolated congenital asplenia at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Familial isolated congenital asplenia community →

No specialists are currently listed for Familial isolated congenital asplenia.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Familial isolated congenital asplenia.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Familial isolated congenital aspleniaForum →

No community posts yet. Be the first to share your experience with Familial isolated congenital asplenia.

Start the conversation →

Latest news about Familial isolated congenital asplenia

No recent news articles for Familial isolated congenital asplenia.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Familial isolated congenital asplenia

What is Familial isolated congenital asplenia?

Familial isolated congenital asplenia (FICA), also known as isolated congenital asplenia or hereditary splenic agenesis, is an extremely rare condition characterized by the complete absence of the spleen from birth without any other associated developmental abnormalities. Unlike asplenia that occurs as part of heterotaxy syndromes (where the arrangement of internal organs is disrupted), familial isolated congenital asplenia occurs as an isolated finding, meaning the heart and other organs develop normally. The condition primarily affects the immune system, as the spleen plays a critical role i

How is Familial isolated congenital asplenia inherited?

Familial isolated congenital asplenia follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Familial isolated congenital asplenia typically begin?

Typical onset of Familial isolated congenital asplenia is neonatal. Age of onset can vary across affected individuals.